AMC Entertainment Holdings delivered the strongest operating quarter in the post-pandemic era in the three months ended June 30, 2026, with consolidated revenue of $1,596.7 million up 14.2 percent year over year and Adjusted EBITDA of $321.4 million, an increase of 69.6 percent from $189.5 million a year earlier. The U.S. markets segment, the bulk of the business, produced Adjusted EBITDA of $285.6 million at a 22.7 percent margin, and the international segment, predominantly the Odeon circuit in the United Kingdom and continental Europe, swung from a single-digit million Adjusted EBITDA contribution a year ago to $35.8 million at a 10.6 percent margin. The Q2 print reframes the equity from a distressed, dilution-trap meme-trade candidate into a fundamentally re-engineered theatrical operator with a working cash machine and a freshly rescheduled debt stack.
The mechanism behind the print, in our reading, is two-part. First, the underlying theatrical exhibition business is enjoying a genuine rebound in attendance and per-cap spending, with U.S. admissions revenue up 13.2 percent and food-and-beverage revenue up 15.3 percent year over year in the second quarter, both outpacing headline industry estimates. Second, AMC has been using its equity at the new, lower post-reverse-split-2024 share price to retire the most onerous tranches of its debt: the Q2 2026 financing activity alone extinguished the New Exchangeable Notes through a 142.1 million share issuance and the 12.75 percent Odeon Senior Secured Notes due 2027 through a $425.0 million new term loan, removing the two nearest-dated fixed-charge towers. The result is a balance sheet that still carries roughly $3.85 billion of corporate borrowings against a stockholders' deficit of $1.45 billion, but with a cash position of $778.4 million, an Adjusted EBITDA run-rate approaching $700 million on an annualized basis, and a clear runway to positive annual operating cash flow.
The load-bearing risk is the share count. The Class A common stock balance grew from 512.9 million shares at year-end 2025 to 892.6 million shares at June 30, 2026, a 74 percent expansion in six months, and the company has explicit registered-direct, at-the-market, and forward-purchase mechanisms that are designed to issue additional equity opportunistically. The next test of the thesis is the Q3 2026 print, which lands in early November 2026 and covers the summer blockbuster window that is, by management's own framing, the single most important attendance period of the calendar. A repeat of the Q2 box-office strength into Q3, combined with stable film-release scheduling, would validate that the company is generating enough free cash flow to fund its debt service without leaning on additional equity issuance; a disappointment in Q3 would force a re-rating that prices in another round of dilution.